These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3438618)

  • 61. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction.
    Yusuf S; Wittes J; Friedman L
    JAMA; 1988 Oct; 260(14):2088-93. PubMed ID: 2901501
    [No Abstract]   [Full Text] [Related]  

  • 62. Optimal timing for interim analyses in clinical trials.
    Togo K; Iwasaki M
    J Biopharm Stat; 2013; 23(5):1067-80. PubMed ID: 23957516
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Stopping rules and estimation problems in clinical trials.
    Hughes MD; Pocock SJ
    Stat Med; 1988 Dec; 7(12):1231-42. PubMed ID: 3231947
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interim analyses for randomized clinical trials: the group sequential approach.
    Pocock SJ
    Biometrics; 1982 Mar; 38(1):153-62. PubMed ID: 7082757
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials.
    Chen YF; Yang Y; Hung HM; Wang SJ
    Contemp Clin Trials; 2011 Jul; 32(4):592-604. PubMed ID: 21540126
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The influence of anticoagulation in elderly subjects with coronary heart disease.
    Roos J
    Postgrad Med J; 1983; 59 Suppl 3():97. PubMed ID: 6359112
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anticoagulants after myocardial infarction.
    Lancet; 1981 Mar; 1(8222):717. PubMed ID: 6110927
    [No Abstract]   [Full Text] [Related]  

  • 69. A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction.
    E.P.S.I.M. Research Group
    N Engl J Med; 1982 Sep; 307(12):701-8. PubMed ID: 7050710
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Drug therapeutic evaluation in acute myocardial infarction.
    Fletcher AP
    J Clin Pathol; 1972 Jul; 25(7):646-7. PubMed ID: 4560846
    [No Abstract]   [Full Text] [Related]  

  • 72. Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomised trial.
    Thuesen L; Jørgensen JR; Kvistgaard HJ; Sørensen JA; Vaeth M; Jensen EB; Jensen JJ; Hagerup L
    Br Med J (Clin Res Ed); 1983 Apr; 286(6371):1107-8. PubMed ID: 6404344
    [No Abstract]   [Full Text] [Related]  

  • 73. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial.
    Ellis SG; Armstrong P; Betriu A; Brodie B; Herrmann H; Montalescot G; Neumann FJ; Smith JJ; Topol E;
    Am Heart J; 2004 Apr; 147(4):E16. PubMed ID: 15077099
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypothesis testing vs. statistical estimation procedures in caries clinical trials.
    Fertig JW
    J Dent Res; 1984 May; 63 Spec No():808-13. PubMed ID: 6586785
    [No Abstract]   [Full Text] [Related]  

  • 75. Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.
    Wilcox RG; Roland JM; Banks DC; Hampton JR; Mitchell JR
    Br Med J; 1980 Mar; 280(6218):885-8. PubMed ID: 6992916
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.
    Muller JE; Morrison J; Stone PH; Rude RE; Rosner B; Roberts R; Pearle DL; Turi ZG; Schneider JF; Serfas DH
    Circulation; 1984 Apr; 69(4):740-7. PubMed ID: 6365350
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Randomized clinical trials: design and analysis.
    Green SB
    Semin Oncol; 1981 Dec; 8(4):417-23. PubMed ID: 7323813
    [No Abstract]   [Full Text] [Related]  

  • 78. Oral anticoagulant in patients surviving myocardial infarction. A new approach to old data.
    Leizorovicz A; Boissel JP
    Eur J Clin Pharmacol; 1983; 24(3):333-6. PubMed ID: 6345177
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Platelet suppressant therapy and oral anticoagulants in the secondary prevention of acute myocardial infarction (authors transl)].
    Theiss W; Blömer H
    Herz; 1979 Oct; 4(5):419-27. PubMed ID: 391686
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Planned interim analysis and its role in cancer clinical trials.
    Geller NL
    J Clin Oncol; 1987 Sep; 5(9):1485-90. PubMed ID: 3625263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.